Cite

HARVARD Citation

    Strongman, H. et al. (2017). Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ open diabetes research and care. 5 (1), p. . [Online]. 
  
Back to record